Diabetic retinopathy: Some cellular, molecular and therapeutic considerations
暂无分享,去创建一个
[1] A. McElduff,et al. Diabetes Control and Complications Trial , 1993 .
[2] Alan W. Stitt,et al. Stereological estimation of Weibel-Palade bodies in the retinal vasculature of normal and diabetic dogs. , 1994, Current eye research.
[3] M. Mcdaniel,et al. Prevention of Diabetic Vascular Dysfunction by Guanidines: Inhibition of Nitric Oxide Synthase Versus Advanced Glycation End-Product Formation , 1993, Diabetes.
[4] T. Kern,et al. Retinopathy in galactosemic dogs continues to progress after cessation of galactosemia. , 1995, Archives of ophthalmology.
[5] R. Ramsay,et al. Progression of diabetic retinopathy after pancreas transplantation for insulin-dependent diabetes mellitus. , 1988, The New England journal of medicine.
[6] P. Beaumont,et al. Glycogen Accumulation in Retinal Neurons and Glial Cells of Streptozotocin-diabetic Rats: Quantitative Electron Microscopy , 1974, Diabetes.
[7] J. J. Wang,et al. Prevalence and associations of epiretinal membranes. The Blue Mountains Eye Study, Australia. , 1997, Ophthalmology.
[8] S. Rees,et al. Nitric oxide synthase immunoreactivity and NADPH diaphorase staining are co-localised in neurons closely associated with the vasculature in rat and human retina , 1995, Brain Research.
[9] Sandra R. Smith,et al. An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[10] D. Zack,et al. Apoptosis in ocular disease: a molecular overview. , 1996, Ophthalmic genetics.
[11] L. P. Aiello. Vascular endothelial growth factor. 20th-century mechanisms, 21st-century therapies. , 1997, Investigative ophthalmology & visual science.
[12] T. Lüscher,et al. The vascular endothelium as a regulator of the ocular circulation: a new concept in ophthalmology? , 1994, Survey of ophthalmology.
[13] Alan W. Stitt,et al. Advanced glycation end products in vitreous: Structural and functional implications for diabetic vitreopathy. , 1998, Investigative ophthalmology & visual science.
[14] L. Aiello,et al. Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[15] H. Thieme,et al. Insulin-induced hyperpolarization in retinal capillary pericytes. , 1993, Investigative ophthalmology & visual science.
[16] T. Lyons,et al. Age-dependent increase in ortho-tyrosine and methionine sulfoxide in human skin collagen is not accelerated in diabetes. Evidence against a generalized increase in oxidative stress in diabetes. , 1997, The Journal of clinical investigation.
[17] T. Kern,et al. Progression of Incipient Diabetic Retinopathy During Good Glycemic Control , 1987, Diabetes.
[18] M. Sanders. The Bowman Lecture. Papilloedema: 'the pendulum of progress'. , 1998, Eye.
[19] J. Baynes. Role of Oxidative Stress in Development of Complications in Diabetes , 1991, Diabetes.
[20] A. Barber,et al. Astrocytes increase barrier properties and ZO-1 expression in retinal vascular endothelial cells. , 1997, Investigative ophthalmology & visual science.
[21] D. Cogan,et al. Retinal vascular patterns. VI. Mural cells of the retinal capillaries. , 1963, Archives of ophthalmology.
[22] J. Bromberg. Pancreatic and islet transplantation for diabetes. , 1993, The New England journal of medicine.
[23] R. Janzer,et al. Astrocytes induce blood–brain barrier properties in endothelial cells , 1987, Nature.
[24] M. P. Carson,et al. Junctional transfer of small molecules in cultured bovine brain microvascular endothelial cells and pericytes. , 1987, Microvascular research.
[25] T. Lyons,et al. Toxicity of Mildly Modified Low-Density Lipoproteins to Cultured Retinal Capillary Endothelial Cells and Pericytes , 1994, Diabetes.
[26] G. Naumann. The Bowman Lecture , 1995, Eye.
[27] D. Eliott,et al. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy. , 1997, Investigative ophthalmology & visual science.
[28] G. Eisenbarth,et al. Insulin prophylaxis in individuals at high risk of type 1 diabetes , 1993, The Lancet.
[29] S. Bursell,et al. Cellular and molecular abnormalities in the vascular endothelium of diabetes mellitus. , 1994, Annual review of medicine.
[30] Norman Fleischer,et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. , 1993 .
[31] J. Eichberg,et al. Alterations in retinal Na+, K(+)-ATPase in diabetes: streptozotocin-induced and Zucker diabetic fatty rats. , 1993, Current eye research.
[32] S. Bursell,et al. The in vivo effect of endothelins on retinal circulation in nondiabetic and diabetic rats. , 1995, Investigative ophthalmology & visual science.
[33] Donald E McMillan,et al. The Effect of Diabetes on Blood Flow Properties , 1983, Diabetes.
[34] G. Schmid-Schönbein,et al. Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy. , 1991, The American journal of pathology.
[35] M. Sporn,et al. Correlation of fibrosis and transforming growth factor-beta type 2 levels in the eye. , 1989, The Journal of clinical investigation.
[36] S. Bursell,et al. Correlation of diacylglycerol level and protein kinase C activity in rat retina to retinal circulation. , 1993, The American journal of physiology.
[37] M. Lorenzi,et al. Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy. , 1996, The Journal of clinical investigation.
[38] R. Wright. Vascular Permeability in Experimental Brain Tumors , 1967, Angiology.
[39] D. Archer,et al. Radiation retinopathy—Clinical, histopathological, ultrastructural and experimental correlations , 1991, Eye.
[40] Chandra L. Theesfeld,et al. Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[41] S. Bursell,et al. Amelioration of Vascular Dysfunctions in Diabetic Rats by an Oral PKC β Inhibitor , 1996, Science.
[42] R. Robertson. Pancreas Transplantation in Humans With Diabetes Mellitus , 1991, Diabetes.
[43] S. Bursell,et al. Retinal blood flow changes in patients with insulin-dependent diabetes mellitus and no diabetic retinopathy. , 1996, Investigative ophthalmology & visual science.
[44] G. Palade,et al. Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. , 1995, Journal of cell science.
[45] B. Reboussin,et al. Antioxidant nutrient intake and diabetic retinopathy: the San Luis Valley Diabetes Study. , 1998, Ophthalmology.
[46] E. Friedman,et al. Advanced glycosylation end products in patients with diabetic nephropathy. , 1991, The New England journal of medicine.
[47] J. Stone,et al. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity , 1995, Nature Medicine.
[48] R. Holman,et al. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .
[49] G. King,et al. Reversal of abnormal retinal hemodynamics in diabetic rats by acarbose, an alpha-glucosidase inhibitor. , 1995, Current eye research.
[50] G. Jerums,et al. Organ specificity of antihypertensive therapy on ocular albumin vascular clearance and albuminuria in the hypertensive diabetic rat. , 1996, Investigative ophthalmology & visual science.
[51] D. Archer,et al. The effect of endothelin 1 on the retinal microvascular pericyte. , 1992, Microvascular research.
[52] B. Buckingham,et al. Biochemical abnormalities in vitreous of humans with proliferative diabetic retinopathy. , 1992, Archives of ophthalmology.
[53] W. Li,et al. Expression of apoptosis regulatory genes by retinal pericytes after rapid glucose reduction. , 1998, Investigative ophthalmology & visual science.
[54] C. Imrie,et al. Pancreatic transplantation , 1990 .
[55] J. Cockcroft,et al. Vitamin E and cardiovascular protection in diabetes , 1997, BMJ.
[56] T. Kern,et al. Abnormalities of Retinal Metabolism in Diabetes or Experimental Galactosemia. III. Effects of Antioxidants , 1996, Diabetes.
[57] J. Finlayson,et al. High glucose downregulates glucose transport activity in retinal capillary pericytes but not endothelial cells. , 1994, Investigative ophthalmology & visual science.
[58] G. Lubec,et al. Reduced susceptibility of nonenzymatically glucosylated glomerular basement membrane to proteases: is thickening of diabetic glomerular basement membranes due to reduced proteolytic degradation? , 1980, Renal physiology.
[59] M. Brownlee,et al. Glycation Products and the Pathogenesis of Diabetic Complications , 1992, Diabetes Care.
[60] Y. Hata,et al. Vascular endothelial growth factor plays a role in hyperpermeability of diabetic retinal vessels. , 1995, Ophthalmic research.
[61] T. Bensaoula,et al. Captopril ameliorates the decreased Na+,K(+)-ATPase activity in the retina of streptozotocin-induced diabetic rats. , 1996, Investigative ophthalmology & visual science.
[62] H. Dvorak,et al. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. , 1995, The American journal of pathology.
[63] E. Keshet,et al. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis , 1992, Nature.
[64] J. Caprioli,et al. Hyperthermia and hypoxia increase tolerance of retinal ganglion cells to anoxia and excitotoxicity. , 1996, Investigative ophthalmology & visual science.
[65] A. Cerami,et al. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. , 1988, The New England journal of medicine.
[66] J. Tarbell,et al. Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group. , 1998, Diabetes.
[67] J. Simpson,et al. Effect of high glucose on permeability of retinal capillary endothelium in vitro. , 1997, Investigative ophthalmology & visual science.
[68] D. DeMets,et al. The Wisconsin epidemiologic study of diabetic retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. , 1984, Archives of ophthalmology.
[69] P. Raskin,et al. Progression of diabetic retinopathy after pancreas transplantation. , 1988, The New England journal of medicine.
[70] D L DeMets,et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. VI. Retinal photocoagulation. , 1987, Ophthalmology.
[71] B L Petrig,et al. Laser Doppler velocimetry study of retinal circulation in diabetes mellitus. , 1986, Archives of ophthalmology.
[72] R. Bucala,et al. Tobacco smoke is a source of toxic reactive glycation products. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[73] E. Agardh,et al. The glutathione levels are reduced in Goto-Kakizaki rat retina, but are not influenced by aminoguanidine treatment. , 1998, Current eye research.
[74] Alan W. Stitt,et al. The combined effects of diabetes and ionising radiation on the rat retina: an ultrastructural study. , 1994, Current eye research.
[75] P. Colville-Nash,et al. Growth factors in angiogenesis: current interest and therapeutic potential. , 1997, Molecular medicine today.
[76] J. Fiddes,et al. Capillary endothelial cells express basic fibroblast growth factor, a mitogen that promotes their own growth , 1987, Nature.
[77] D. Ingber,et al. A heparin-binding angiogenic protein--basic fibroblast growth factor--is stored within basement membrane. , 1988, The American journal of pathology.
[78] M. Gillies,et al. High glucose inhibits retinal capillary pericyte contractility in vitro. , 1993, Investigative ophthalmology & visual science.
[79] M. Boulton,et al. Intravitreal growth factors in proliferative diabetic retinopathy: correlation with neovascular activity and glycaemic management , 1997, The British journal of ophthalmology.
[80] H. Suzuki,et al. Ocular vascular endothelial growth factor levels in diabetic rats are elevated before observable retinal proliferative changes , 1997, Diabetologia.
[81] P. D'Amore,et al. Mechanisms of retinal and choroidal neovascularization. , 1994, Investigative ophthalmology & visual science.
[82] G. King,et al. Diabetic vascular dysfunctions: a model of excessive activation of protein kinase C. , 1997, Kidney international. Supplement.
[83] Alan W. Stitt,et al. Retinal vascular endothelial cell endocytosis increases in early diabetes. , 1995, Laboratory investigation; a journal of technical methods and pathology.
[84] Joan W. Miller,et al. Systemic hyperoxia decreases vascular endothelial growth factor gene expression in ischemic primate retina. , 1997, Archives of ophthalmology.
[85] H. Freyberger,et al. Vitreous levels of the insulin-like growth factors I and II, and the insulin-like growth factor binding proteins 2 and 3, increase in neovascular eye disease. Studies in nondiabetic and diabetic subjects. , 1993, The Journal of clinical investigation.
[86] R. Klein,et al. Cigarette smoking and ten-year progression of diabetic retinopathy. , 1996, Ophthalmology.
[87] J. Skou,et al. [1] Overview: The Na,K-pump , 1988 .
[88] E. Kohner,et al. Toxic action of advanced glycation end products on cultured retinal capillary pericytes and endothelial cells: relevance to diabetic retinopathy , 1997, Diabetologia.
[89] T. Hohman,et al. An aldose reductase inhibitor and aminoguanidine prevent vascular endothelial growth factor expression in rats with long-term galactosemia. , 1997, Archives of ophthalmology.
[90] C. Zucker,et al. Expression of vascular endothelial growth factor in the human retina and in nonproliferative diabetic retinopathy. , 1998, The American journal of pathology.
[91] S. Bursell,et al. Vitamin E prevents diabetes-induced abnormal retinal blood flow via the diacylglycerol-protein kinase C pathway. , 1995, The American journal of physiology.
[92] L. Aiello,et al. Vascular endothelial growth factor in ocular neovascularization and proliferative diabetic retinopathy. , 1997, Diabetes/metabolism reviews.
[93] E. Kohner,et al. Oxygen reactivity in diabetes mellitus: effect of hypertension and hyperglycaemia. , 1994, Clinical science.
[94] E. Kohner,et al. Autoregulation of retinal blood flow in diabetic retinopathy measured by the blue-light entoptic technique. , 1987, Ophthalmology.
[95] H. Meiselman,et al. Decreased Deformability of Polymorphonuclear Leukocytes in Diabetic Cats , 1996, Microcirculation.
[96] J. Bernhagen,et al. An agent cleaving glucose-derived protein crosslinks in vitro and in vivo , 1996, Nature.
[97] D. R. Anderson,et al. Effect of CO2 on intracellular pH and contraction of retinal capillary pericytes. , 1997, Investigative ophthalmology & visual science.
[98] E. Cagliero,et al. Fibronectin overexpression in retinal microvessels of patients with diabetes. , 1996, Investigative ophthalmology & visual science.
[99] J. Nyengaard,et al. Hyperglycemic Pseudohypoxia and Diabetic Complications , 1993, Diabetes.
[100] D. R. Anderson,et al. Relaxation of retinal pericyte contractile tone through the nitric oxide-cyclic guanosine monophosphate pathway. , 1994, Investigative ophthalmology & visual science.
[101] J. Nyengaard,et al. Elevated glucose levels increase retinal glycolysis and sorbitol pathway metabolism. Implications for diabetic retinopathy. , 1995, Investigative ophthalmology & visual science.
[102] E. Kohner,et al. Retinal blood flow in diabetic retinopathy. , 1992, BMJ.
[103] D. Weinberger,et al. Non-retinovascular leakage in diabetic maculopathy. , 1995, The British journal of ophthalmology.
[104] A. Kashiwagi,et al. Impaired Activation of Glucose Oxidation and NADPH Supply in Human Endothelial Cells Exposed to H2O2 in High-Glucose Medium , 1995, Diabetes.
[105] H. Lodish,et al. Molecular Physiology of Glucose Transporters , 1990, Diabetes Care.
[106] J. Forrester,et al. Glucose-dependent regulation of DNA synthesis in bovine retinal endothelial cells. , 1998, Current eye research.
[107] C. Riva,et al. Effect of an insulin-induced decrease in blood glucose on the human diabetic retinal circulation. , 1987, Ophthalmology.
[108] G. Carmignoto,et al. Nerve growth factor promotes functional recovery of retinal ganglion cells after ischemia. , 1993, Investigative ophthalmology & visual science.
[109] R. Klein,et al. The 14-year incidence of visual loss in a diabetic population. , 1998, Ophthalmology.
[110] D. Hatchell,et al. Neutrophils plug capillaries in acute experimental retinal ischemia. , 1994, Microvascular research.
[111] Richard Wise,et al. Science, medicine, and the future , 1998 .
[112] J. Forrester,et al. Role of glucose regulatory mechanisms in diabetic retinopathy. , 1995, The British journal of ophthalmology.
[113] D. Green,et al. The central executioners of apoptosis: caspases or mitochondria? , 1998, Trends in cell biology.
[114] Alan W. Stitt,et al. Diabetic retinopathy: quantitative variation in capillary basement membrane thickening in arterial or venous environments. , 1994, The British journal of ophthalmology.
[115] D. Puro,et al. Expression of transforming growth factor-beta s and their receptors by human retinal glial cells. , 1998, Current eye research.
[116] Alan W. Stitt,et al. Constitutive nitric oxide synthase expression in retinal vascular endothelial cells is suppressed by high glucose and advanced glycation end products. , 1998, Diabetes.
[117] J. Cunha-Vaz,et al. Effect of Sorbinil on Blood-Retinal Barrier in Early Diabetic Retinopathy , 1986, Diabetes.
[118] L. Aiello,et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. , 1994, The New England journal of medicine.
[119] A. Wyllie,et al. Apoptosis: A Basic Biological Phenomenon with Wide-ranging Implications in Tissue Kinetics , 1972, British Journal of Cancer.
[120] S. O’Rahilly,et al. Science, medicine, and the future Non-insulin dependent diabetes mellitus: the gathering storm , 1997, BMJ.
[121] M. R. Petersen,et al. Progression of diabetic retinopathy after pancreas transplantation. The University of Michigan Pancreas Transplant Evaluation Committee. , 1990, Ophthalmology.
[122] H Lestradet,et al. [The discovery of insulin]. , 1996, Bulletin de l'Academie nationale de medecine.
[123] S. Bursell,et al. Regulation of retinal hemodynamics in diabetic rats by increased expression and action of endothelin-1. , 1996, Investigative ophthalmology & visual science.
[124] Alan W. Stitt,et al. Increased Levels of Advanced Glycation Endproducts in the Lenses and Blood Vessels of Cigarette Smokers , 1998, Molecular medicine.
[125] N. Laver,et al. The role of aldose reductase in diabetic retinopathy: Prevention and intervention studies , 1995, Progress in Retinal and Eye Research.
[126] Joan W. Miller,et al. Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. , 1994, The American journal of pathology.
[127] J. Williamson,et al. Vascular dysfunction induced by elevated glucose levels in rats is mediated by vascular endothelial growth factor. , 1997, The Journal of clinical investigation.
[128] Y. Ogura,et al. Role of leukocytes in diabetic microcirculatory disturbances. , 1997, Microvascular research.
[129] B. V. von Specht,et al. Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease. , 1998, Circulation.
[130] J. Stone,et al. Role of astrocytes in the control of developing retinal vessels. , 1997, Investigative ophthalmology & visual science.
[131] D. Goeddel,et al. Vascular endothelial growth factor is a secreted angiogenic mitogen. , 1989, Science.
[132] S. Cousins,et al. Prevention of experimental proliferative vitreoretinopathy with a biodegradable intravitreal implant for the sustained release of fluorouracil. , 1994, Archives of ophthalmology.
[133] M. Catherwood,et al. Glucose-induced oxidative stress in vascular contractile cells: comparison of aortic smooth muscle cells and retinal pericytes. , 1998, Diabetes.
[134] H. Kolb,et al. Histochemical demonstration of glycogen in neurons of the cat retina. , 1996, Investigative ophthalmology & visual science.
[135] E S Gragoudas,et al. Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate. , 1996, Archives of ophthalmology.
[136] R. Bucala,et al. Pathogenic effects of advanced glycosylation: biochemical, biologic, and clinical implications for diabetes and aging. , 1994, Laboratory investigation; a journal of technical methods and pathology.
[137] F Jung,et al. Retinal microcirculation in patients with diabetes mellitus: dynamic and morphological analysis of perifoveal capillary network. , 1991, The British journal of ophthalmology.
[138] K. Chalam,et al. Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma. , 1998, Ophthalmology.
[139] D. L. Fry. Certain Histological and Chemical Responses of the Vascular Interface to Acutely Induced Mechanical Stress in the Aorta of the Dog , 1969, Circulation research.
[140] A. Eller,et al. ANTIHISTAMINES REDUCE BLOODRETINAL BARRIER PERMEABILITY IN TYPE I (INSULIN-DEPENDENT) DIABETIC PATIENTS WITH NONPROLIFERATIVE RETINOPATHY: A Pilot Study , 1995, Retina.
[141] M. Gimbrone,et al. Influence of hemodynamic forces on vascular endothelial function. In vitro studies of shear stress and pinocytosis in bovine aortic cells. , 1984, The Journal of clinical investigation.
[142] H. Hammes,et al. Upregulation of the vascular endothelial growth factor/vascular endothelial growth factor receptor system in experimental background diabetic retinopathy of the rat. , 1998, Diabetes.
[143] M. Lorenzi,et al. Increased expression of basement membrane collagen in human diabetic retinopathy. , 1994, The Journal of clinical investigation.
[144] R. Linsenmeier,et al. Retinal hypoxia in long-term diabetic cats. , 1998, Investigative ophthalmology & visual science.
[145] J. Folkman,et al. Increased Vascular Endothelial Growth Factor Levels in the Vitreous of Eyes With Proliferative Diabetic Retinopathy , 1995 .
[146] C. Riva,et al. Retinal hemodynamics in proliferative diabetic retinopathy. A laser Doppler velocimetry study. , 1993, Investigative ophthalmology & visual science.
[147] D TOUSSAINT,et al. Retinal vascular patterns. IV. Diabetic retinopathy. , 1961, Archives of ophthalmology.
[148] J S Tiedeman,et al. Retinal oxygen consumption during hyperglycemia in patients with diabetes without retinopathy. , 1998, Ophthalmology.
[149] B. Margetts. United Kingdom prospective diabetes study , 1995, BMJ.
[150] Hidehiro Ishii,et al. Vascular Endothelial Growth Factor–Induced Retinal Permeability Is Mediated by Protein Kinase C In Vivo and Suppressed by an Orally Effective β-Isoform–Selective Inhibitor , 1997, Diabetes.
[151] G. Jaffe,et al. An intravitreal sustained-release triamcinolone and 5-fluorouracil codrug in the treatment of experimental proliferative vitreoretinopathy. , 1998, Archives of ophthalmology.
[152] Alan W. Stitt,et al. Selective loss of vascular smooth muscle cells in the retinal microcirculation of diabetic dogs. , 1994, The British journal of ophthalmology.
[153] S. Bursell,et al. Normalization of Diacylglycerol-Protein Kinase C Activation by Vitamin E in Aorta of Diabetic Rats and Cultured Rat Smooth Muscle Cells Exposed to Elevated Glucose Levels , 1994, Diabetes.
[154] B. Petrig,et al. Altered retinal vascular response to 100% oxygen breathing in diabetes mellitus. , 1984, Ophthalmology.
[155] L. Mandarino. Current Hypotheses for the Biochemical Basis of Diabetic Retinopathy , 1992, Diabetes Care.
[156] Aminoguanidine treatment inhibits the development of experimental diabetic retinopathy. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[157] A. Vinik,et al. Progression of Diabetic Retionopathy after Pancreas Transplantation , 1990 .
[158] B. Hering,et al. Recent Achievements in Experimental and Clinical Islet Transplantation , 1991, Diabetic medicine : a journal of the British Diabetic Association.
[159] K. Tracey,et al. Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. , 1991, The Journal of clinical investigation.
[160] J. Stone,et al. Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.
[161] B. Gallacher,et al. Glucose-Induced Protein Kinase C Activation Regulates Vascular Permeability Factor mRNA Expression and Peptide Production by Human Vascular Smooth Muscle Cells In Vitro , 1997, Diabetes.
[162] M. Pfeifer,et al. Aldose Reductase Inhibitors: The End of an Era or the Need for Different Trial Designs? , 1997, Diabetes.
[163] Toyoshi Inoguchi,et al. Induction of Resistance to Endothelin-1's Biochemical Actions by Elevated Glucose Levels in Retinal Pericytes , 1992, Diabetes.
[164] Alan W. Stitt,et al. Characterization of the advanced glycation end-product receptor complex in human vascular endothelial cells. , 1999, Biochemical and biophysical research communications.
[165] G. Brown,et al. Basic fibroblast growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. , 1990, Archives of ophthalmology.
[166] Alan W. Stitt,et al. Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats. , 1997, The American journal of pathology.
[167] B. Petrig,et al. Diabetic Glycemic Control and Retinal Blood Flow , 1990, Diabetes.
[168] D L DeMets,et al. The Wisconsin epidemiologic study of diabetic retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. , 1984, Archives of ophthalmology.
[169] D. Greene,et al. Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. , 1987, The New England journal of medicine.
[170] T. Merimee,et al. Diabetic retinopathy. A synthesis of perspectives. , 1990, The New England journal of medicine.
[171] D. Archer,et al. A morphologic and autoradiographic study of cell death and regeneration in the retinal microvasculature of normal and diabetic rats. , 1985, American journal of ophthalmology.
[172] S. Bursell,et al. Specific retinal diacylglycerol and protein kinase C beta isoform modulation mimics abnormal retinal hemodynamics in diabetic rats. , 1997, Investigative ophthalmology & visual science.
[173] K Miyamoto,et al. In vivo demonstration of increased leukocyte entrapment in retinal microcirculation of diabetic rats. , 1998, Investigative ophthalmology & visual science.
[174] Mara,et al. High glucose induces DNA damage in cultured human endothelial cells. , 1986, The Journal of clinical investigation.
[175] Stephen J. Aldington,et al. United Kingdom Prospective Diabetes Study, 30: diabetic retinopathy at diagnosis of non-insulin-dependent diabetes mellitus and associated risk factors. , 1998, Archives of ophthalmology.
[176] T. Kern,et al. Aldose Reductase Inhibition Fails to Prevent Retinopathy in Diabetic and Galactosemic Dogs , 1993, Diabetes.
[177] T. Kern,et al. Retinopathy in animal models of diabetes. , 1995, Diabetes/metabolism reviews.
[178] Robertson Rp. Seminars in medicine of the Beth Israel Hospital, Boston: Pancreatic and islet transplantation for diabetes--cures or curiosities? , 1992 .
[179] Joan W. Miller,et al. Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. , 1996, Ophthalmology.
[180] Alan W. Stitt,et al. Expression of vascular endothelial growth factor (VEGF) and its receptors is regulated in eyes with intra‐ocular tumours , 1998, The Journal of pathology.
[181] R. Vracko,et al. Manifestations of diabetes mellitus--their possible relationships to an underlying cell defect. A review. , 1974, The American journal of pathology.
[182] L. Aiello,et al. Adenosine mediates hypoxic induction of vascular endothelial growth factor in retinal pericytes and endothelial cells. , 1996, Investigative ophthalmology & visual science.
[183] D. Wagner,et al. P-selectin, a granule membrane protein of platelets and endothelial cells, follows the regulated secretory pathway in AtT-20 cells , 1992, The Journal of cell biology.
[184] T. Hohman,et al. Diabetic-like retinopathy: early and late intervention therapies in galactose-fed rats. , 1998, Investigative ophthalmology & visual science.
[185] E. Keshet,et al. Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases. , 1995, Laboratory investigation; a journal of technical methods and pathology.
[186] N. Ruderman,et al. Endothelium-dependent inhibition of Na(+)-K+ ATPase activity in rabbit aorta by hyperglycemia. Possible role of endothelium-derived nitric oxide. , 1992, The Journal of clinical investigation.
[187] A. Cerami,et al. Aminoguanidine prevents diabetes-induced arterial wall protein cross-linking. , 1986, Science.
[188] S. Chakrabarti,et al. Endothelin-1 and endothelin-3-like immunoreactivity in the eyes of diabetic and non-diabetic BB/W rats. , 1997, Diabetes research and clinical practice.
[189] Philip D. Harvey,et al. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 , 1998, BMJ.
[190] M. Karmazyn,et al. Augmented retinal endothelin-1, endothelin-3, endothelinA and endothelinB gene expression in chronic diabetes. , 1998, Current eye research.
[191] Alan W. Stitt,et al. Histological and ultrastructural investigation of retinal microaneurysm development in diabetic patients. , 1995, The British journal of ophthalmology.
[192] D. Hatchell,et al. Alterations in stimulus-induced integrin expression in peripheral blood neutrophils of patients with diabetic retinopathy. , 1997, The American journal of the medical sciences.
[193] L. Aiello,et al. Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor. , 1998, Diabetes.
[194] P A D'Amore,et al. Inhibition of capillary endothelial cell growth by pericytes and smooth muscle cells , 1987, The Journal of cell biology.
[195] T. Lyons. Glycation, oxidation, and glycoxidation reactions in the development of diabetic complications. , 1995, Contributions to nephrology.
[196] E. Cagliero,et al. Increased expression of basement membrane components in human endothelial cells cultured in high glucose. , 1988, The Journal of clinical investigation.
[197] E. Leite,et al. Characterization of the Early Stages of Diabetic Retinopathy by Vitreous Fluorophotometry , 1985, Diabetes.
[198] A. Donker,et al. Endothelial dysfunction and pathogenesis of diabetic angiopathy. , 1997, Cardiovascular research.
[199] H. Inomata,et al. Ultrastructure of retinal vessels in diabetic patients. , 1993, The British journal of ophthalmology.
[200] M. Tsacopoulos,et al. Nitric oxide controls arteriolar tone in the retina of the miniature pig. , 1995, Investigative ophthalmology & visual science.
[201] Gardner Tw. Histamine, ZO-1 and increased blood-retinal barrier permeability in diabetic retinopathy. , 1995 .
[202] Lois E. H. Smith,et al. Oligodeoxynucleotides inhibit retinal neovascularization in a murine model of proliferative retinopathy. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[203] G. Lutty,et al. Vascular endothelial growth factor and vascular permeability changes in human diabetic retinopathy. , 1997, Investigative ophthalmology & visual science.
[204] G. Paolisso,et al. Oxidative Stress and Diabetic Vascular Complications , 1996, Diabetes Care.
[205] Alan W. Stitt,et al. The 67-kd laminin receptor is preferentially expressed by proliferating retinal vessels in a murine model of ischemic retinopathy. , 1998, The American journal of pathology.
[206] Hypoglycemia in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group. , 1997, Diabetes.
[207] B. Glasgow,et al. GLUT1 glucose transporter expression in the diabetic and nondiabetic human eye. , 1994, Investigative ophthalmology & visual science.
[208] C E Riva,et al. Retinal vascular autoregulation in diabetes mellitus. , 1982, Ophthalmology.
[209] B. Glaser. Extracellular modulating factors and the control of intraocular neovascularization. An overview. , 1988, Archives of ophthalmology.
[210] W. Schwarz,et al. Structure-function relationships of cation binding in the Na+/K(+)-ATPase. , 1993, Biochimica et biophysica acta.
[211] R. Danis,et al. Insulin-like growth factor-1 retinal microangiopathy in the pig eye. , 1997, Ophthalmology.
[212] R. Folberg,et al. Vascular endothelial growth factor upregulation in human central retinal vein occlusion. , 1998, Ophthalmology.
[213] T. Gardner,et al. Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. , 1998, The Journal of clinical investigation.
[214] G T Feke,et al. Retinal circulatory abnormalities in type 1 diabetes. , 1994, Investigative ophthalmology & visual science.
[215] J. Folkman,et al. Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. , 1993, Laboratory investigation; a journal of technical methods and pathology.
[216] D. R. Anderson,et al. Adenosine-induced relaxation of cultured bovine retinal pericytes. , 1997, Investigative ophthalmology & visual science.
[217] M. Jacobson,et al. Measurement of adenosine concentration in aqueous and vitreous. , 1998, Investigative ophthalmology & visual science.
[218] T. Hohman,et al. Diabetic-like retinopathy ameliorated with the aldose reductase inhibitor WAY-121,509. , 1996, Investigative ophthalmology & visual science.
[219] K. Kinzler,et al. A model for p53-induced apoptosis , 1997, Nature.
[220] R. Danis,et al. Inhibition of intraocular neovascularization caused by retinal ischemia in pigs by PKCbeta inhibition with LY333531. , 1998, Investigative ophthalmology & visual science.
[221] J. Lingrel. Na,K-ATPase: Isoform structure, function, and expression , 1992, Journal of bioenergetics and biomembranes.
[222] R. Klein,et al. Ten-year incidence of visual loss in a diabetic population. , 1994, Ophthalmology.
[223] Y. Nishizuka,et al. The role of protein kinase C in transmembrane signalling. , 1986, Annual review of cell biology.